Antibodies from camels and llamas could be used as a new treatment for patients with COVID-19, according to a new study. The treatment would be injected into patients through a nasal spray.
Follow Israel Hayom on Facebook and Twitter
Published in the academic journal Nature Communications, the study suggests that nanobodies – single domain antibodies derived from llamas and camels – could be used to fight the virus due to the way they bind to and neutralize viral cells.
Further study found that nanobodies were able to fight off the alpha and beta variants of the coronavirus.
Moreover, in Israel, researchers last month indicated that a low-cost generic drug appears to have a strong ability to fight COVID-19.
Subscribe to Israel Hayom's daily newsletter and never miss our top stories!
A research team from the Hebrew University of Jerusalem hypothesized at the start of the pandemic that fenofibrate, a generic low-fat drug, could help patients with COVID-19.
Despite the massive vaccination campaign, the infection figures remain very high in the Jewish state, more than 6,000 new cases have been reported in 24 hours and the morbidity rate is struggling to drop.
i24NEWS contributed to this report.
